The natural history of multiple sclerosis: a geographically based study. 5. The clinical features and natural history of primary progressive multiple sclerosis.
about
Chronic cerebrospinal venous insufficiency in patients with multiple sclerosisInterferon beta for secondary progressive multiple sclerosisInterferon beta for secondary progressive multiple sclerosisA lipidomic approach to the study of human CD4(+) T lymphocytes in multiple sclerosisPrimary progressive multiple sclerosis: current therapeutic strategies and future perspectivesNatural history of primary progressive multiple sclerosisGrey matter damage in multiple sclerosis: a pathology perspectivePrimary progressive multiple sclerosis: progress and challenges.Imaging primary progressive multiple sclerosis: the contribution of structural, metabolic, and functional MRI techniques.Sex hormones: a role in the control of multiple sclerosis?Progressive multiple sclerosis: from pathogenic mechanisms to treatment.Patient-orientated longitudinal study of multiple sclerosis in south west England (The South West Impact of Multiple Sclerosis Project, SWIMS) 1: protocol and baseline characteristics of cohort.Evidence for a two-stage disability progression in multiple sclerosisThe natural history of multiple sclerosis: a geographically based study 10: relapses and long-term disabilityThe role of advanced magnetic resonance imaging techniques in primary progressive MS.Obesity during childhood and adolescence increases susceptibility to multiple sclerosis after accounting for established genetic and environmental risk factors.Isoniazid in autoimmunity: a trigger for multiple sclerosis?T2 lesion location really matters: a 10 year follow-up study in primary progressive multiple sclerosis.Relapses and disability accumulation in progressive multiple sclerosisMechanisms of disability progression in primary progressive multiple sclerosis: are they different from secondary progressive multiple sclerosis?Validating predictors of disease progression in a large cohort of primary-progressive multiple sclerosis based on a systematic literature review.Age and disability accumulation in multiple sclerosis.Symptomatic therapy and rehabilitation in primary progressive multiple sclerosisThe presence of glutamic acid at positions 71 or 74 in pocket 4 of the HLA-DRbeta1 chain is associated with the clinical course of multiple sclerosisMale Sex Is Independently Associated with Faster Disability Accumulation in Relapse-Onset MS but Not in Primary Progressive MSMechanisms and pharmacology of neuropathic pain in multiple sclerosis.A prospective web-based patient-centred interactive study of long-term disabilities, disabilities perception and health-related quality of life in patients with multiple sclerosis in The Netherlands: the Dutch Multiple Sclerosis Study protocol.Overview of primary progressive multiple sclerosis (PPMS): similarities and differences from other forms of MS, diagnostic criteria, pros and cons of progressive diagnosis.Mitoxantrone as a potential therapy for primary progressive multiple sclerosis.Clinical characteristics of progressive relapsing multiple sclerosis.Cost-Effectiveness of Treatments for Relapsing Remitting Multiple Sclerosis: A French Societal PerspectiveEvidence for early neurodegeneration in the cervical cord of patients with primary progressive multiple sclerosisClinical and pathological insights into the dynamic nature of the white matter multiple sclerosis plaque.Abnormalities in normal appearing tissues in early primary progressive multiple sclerosis and their relation to disability: a tissue specific magnetisation transfer studyDisability evolution in multiple sclerosis: how to deal with missing transition times in the Markov model?MSBase: an international, online registry and platform for collaborative outcomes research in multiple sclerosis.Relation of helicobacter pylori infection and multiple sclerosis in Iranian patients.Mortality in patients with multiple sclerosisAnalysis of nociception, sex and peripheral nerve innervation in the TMEV animal model of multiple sclerosis.Age of onset in concordant twins and other relative pairs with multiple sclerosis.
P2860
Q22242024-7FC16A30-E4B5-4FF7-A49F-B682A706C324Q24203879-040E4F3C-90A9-46FB-A24C-AF8E47BAB223Q24240509-64E07CC8-0F8B-4325-B6D4-FDF7A969CA9FQ28384280-7D4D8508-4868-46F4-B5A9-082CFEC9290CQ29030703-7D03D7E6-68E7-44B6-9309-4B20DD174964Q29391465-8603C658-49CA-4774-899B-C21B5D9748E7Q30586246-89C06E80-6B66-4E06-932B-B7EBFF66C0ADQ30590258-13F7BA0B-594C-4518-9B9E-1E2F10A2D31BQ30940046-86647E7B-D034-4FCF-9CB1-8459748CC28CQ31037759-03B4865A-2AB2-4ADD-AD1D-ADD5DDA7104CQ31139925-8B54DD52-84F3-429E-AEE5-AEB174C9BFE7Q33712460-BB3E0F1B-A09A-4AA6-8B62-3B2BB77592DEQ33944184-25441477-8001-4995-9F46-35412167B67CQ33944200-1AB7C961-3C77-4885-A06F-962A5E594ABAQ33981654-1E11037F-1EA6-40CF-8FE5-EB22757DAB7FQ34266877-1B510D49-F05F-4AA8-AB64-0F0CEE142284Q34389312-FACA1C03-7CF2-41F3-9D1E-7FE69C996F73Q34410090-DC81CEF8-AF1C-41CA-9F96-093E3DFB6D0BQ35106567-572E0AD8-FA3A-45D3-8176-E469D744D92CQ35112343-E99D9449-2499-472F-977D-D37990B0C1DDQ35126308-BCA67198-B56D-48A2-883A-539E329879E3Q35230950-9BB461A5-116B-4CE9-BAC8-01333725978DQ35377529-917E6822-A36E-483A-8FF4-7A5E83C58E6FQ35487679-093881D6-75D1-4C5B-8F35-E3E649633A8EQ35653675-773BAE67-7BD8-4518-9A50-86E117316D7CQ35731415-7420BBC1-8127-438A-BD64-35D0427C791CQ35736039-14616119-B8B1-46AB-A199-B3922BC358E5Q35818129-A07943B8-9FE9-44BC-BBA8-707F07121CCFQ35818165-7D83EEDF-D3CF-4517-A75E-9AC52B0FB3AAQ35870214-048F2224-5E94-48CB-B650-C7874A48A2DDQ35961279-5E1C79ED-7B07-41C0-B098-55E64FE45711Q36186773-B61086AA-97F9-47F8-A4DA-D3BD1136AECDQ36218017-A87760B4-F81B-48FD-B504-BFFFE178692FQ36226260-6B8B2D54-6527-4813-9C82-73E37D9330A6Q36704225-164D6A7B-767A-453C-BFEA-FB0E46F60B17Q36722176-EDB443FC-6078-4222-A792-C3E2EE8E8EC3Q37032058-D1EA501C-A3FB-478E-BF02-EBA10514360DQ37163309-3A0E7CD2-CB53-4FD1-90CE-1DDB7821B0C9Q37169940-E597BFAA-6124-4B25-A05B-C6EAF66120A5Q37272954-4EC9BAE0-90F7-478E-BC93-5567D5235A6C
P2860
The natural history of multiple sclerosis: a geographically based study. 5. The clinical features and natural history of primary progressive multiple sclerosis.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年学术文章
@wuu
1999年学术文章
@zh
1999年学术文章
@zh-cn
1999年学术文章
@zh-hans
1999年学术文章
@zh-my
1999年学术文章
@zh-sg
1999年學術文章
@yue
1999年學術文章
@zh-hant
name
The natural history of multipl ...... rogressive multiple sclerosis.
@en
The natural history of multipl ...... rogressive multiple sclerosis.
@nl
type
label
The natural history of multipl ...... rogressive multiple sclerosis.
@en
The natural history of multipl ...... rogressive multiple sclerosis.
@nl
prefLabel
The natural history of multipl ...... rogressive multiple sclerosis.
@en
The natural history of multipl ...... rogressive multiple sclerosis.
@nl
P2093
P2860
P356
P1433
P1476
The natural history of multipl ...... rogressive multiple sclerosis.
@en
P2093
Baskerville J
Cottrell DA
Koopman WJ
Kremenchutzky M
P2860
P304
P356
10.1093/BRAIN/122.4.625
P407
P478
122 ( Pt 4)
P577
1999-04-01T00:00:00Z